GenDx and Illumina Netherlands BV have recently signed a reseller agreement. According to which GenDx is appointed as a non-exclusive reseller of Illumina products, instruments, such as MiSeq® and MiniSeq® and reagents, as well as maintenance contracts for the field of HLA sequencing in a restricted number of countries, including Benelux, Italy, United Kingdom, Germany and Finland. GenDx is also allowed to deliver these Illumina products in these countries when represented by its own local distributor. This agreement allows GenDx and its local distributors to support the full workflow for HLA typing laboratories, including the NGS platform, platform specific NGS reagents, as well as dedicated HLA-NGSgo® reagents and NGSengine® software for allelic level HLA typing analyses. Wietse Mulder PhD, CEO of GenDx commented: “We are very pleased to have signed this agreement and we are looking forward to the collaboration with Illumina. It complements our IVD offering to a full package, as earlier this year GenDx received the CE-IVD marking for the full workflow on Illumina platform. This new relationship with Illumina reinforces our leading position in the field of HLA typing. It also fits to our company’s mission; being an independent organisation with respect to our business partners. At GenDx, our efforts are focused on molecular diagnostics solutions and combination of scientific innovation with reliability, ultimately leading to a better outcome of transplantation”. Readers of this message, who are interested in HLA typing by NGS and wonder whether they could benefit from this new agreement, can receive more information by contacting their local GenDx distributor or contacting GenDx directly.